全文获取类型
收费全文 | 36842篇 |
免费 | 2162篇 |
国内免费 | 163篇 |
专业分类
耳鼻咽喉 | 279篇 |
儿科学 | 1217篇 |
妇产科学 | 1004篇 |
基础医学 | 4184篇 |
口腔科学 | 487篇 |
临床医学 | 6242篇 |
内科学 | 6779篇 |
皮肤病学 | 408篇 |
神经病学 | 3485篇 |
特种医学 | 1016篇 |
外国民族医学 | 1篇 |
外科学 | 3677篇 |
综合类 | 366篇 |
现状与发展 | 1篇 |
一般理论 | 50篇 |
预防医学 | 4821篇 |
眼科学 | 519篇 |
药学 | 2090篇 |
中国医学 | 38篇 |
肿瘤学 | 2503篇 |
出版年
2023年 | 200篇 |
2022年 | 296篇 |
2021年 | 655篇 |
2020年 | 453篇 |
2019年 | 722篇 |
2018年 | 874篇 |
2017年 | 631篇 |
2016年 | 697篇 |
2015年 | 743篇 |
2014年 | 1132篇 |
2013年 | 1765篇 |
2012年 | 2561篇 |
2011年 | 2661篇 |
2010年 | 1445篇 |
2009年 | 1273篇 |
2008年 | 2389篇 |
2007年 | 2640篇 |
2006年 | 2507篇 |
2005年 | 2440篇 |
2004年 | 2234篇 |
2003年 | 2178篇 |
2002年 | 2123篇 |
2001年 | 441篇 |
2000年 | 418篇 |
1999年 | 454篇 |
1998年 | 486篇 |
1997年 | 375篇 |
1996年 | 345篇 |
1995年 | 345篇 |
1994年 | 293篇 |
1993年 | 291篇 |
1992年 | 225篇 |
1991年 | 214篇 |
1990年 | 225篇 |
1989年 | 202篇 |
1988年 | 198篇 |
1987年 | 191篇 |
1986年 | 169篇 |
1985年 | 171篇 |
1984年 | 172篇 |
1983年 | 164篇 |
1982年 | 169篇 |
1981年 | 180篇 |
1980年 | 155篇 |
1979年 | 89篇 |
1978年 | 98篇 |
1977年 | 98篇 |
1976年 | 62篇 |
1975年 | 59篇 |
1974年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
131.
At present there is no curative treatment for sarcoidosis. Immunosuppressive and/or immunomodulatory drugs can, however, be used for controlling the disease. Corticosteroids remain the mainstay of therapy. They function by suppressing the pro-inflammatory cytokines and chemokines that are involved in cell-mediated immune responses and granuloma formation. Only in a select group of patients is it justifiable to use these drugs, after careful evaluation of the pros and cons. Importantly, disease severity, e.g. threatened organ functions, and not disease activity itself should be the deciding factor in this process. In the case of parenchymal involvement, there is substantial evidence that corticosteroids can improve respiratory symptoms and chest radiography and lung function parameters over 6-24 months. Other generally acknowledged (empirical) criteria for systemic treatment include neurological, cardiac and sight-threatening ocular involvement and hypercalcaemia. Remarkably, despite >50 yrs of use, there is no proof of long-term (survival) benefit from corticosteroid treatment. In addition, there are still no data regarding the optimal dose and duration of corticosteroid or other immunosuppressive therapy. One of the weightiest questions remaining is whether or not these drugs can prevent scarring in patients with a fibrogenic phenotype. As new agents, including infliximab and thalidomide, enter the stage and new diagnostic tools are now available, there is clearly a momentum to design multicentric randomised controlled trials with long enough follow-up (>5 yrs) to answer this pivotal question. 相似文献
132.
What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? 总被引:5,自引:0,他引:5
Keiichiro Yoshinaga Benjamin J W Chow Kathryn Williams Li Chen Robert A deKemp Linda Garrard Alexander Lok-Tin Szeto May Aung Ross A Davies Terrence D Ruddy Rob S B Beanlands 《Journal of the American College of Cardiology》2006,48(5):1029-1039
OBJECTIVES: The objective was to determine the prognostic value of rubidium-82 (82Rb) positron emission tomography (PET) myocardial perfusion imaging (MPI). BACKGROUND: 82Rb PET MPI accurately diagnoses coronary artery disease (CAD). However, there are limited data evaluating its prognostic value. METHODS: Follow-up (3.1 +/- 0.9 years) was obtained in 367 patients who underwent dipyridamole 82Rb PET MPI. Patients were divided into groups based on their summed stress score (SSS): group I, normal (<4); group II, mild (4 to 7); and group III, moderate (8 to 11) to severe (> or =12). RESULTS: There were significant differences among patients in the 3 SSS groups for hard events (cardiac death and myocardial infarction [MI]) (p < 0.001) and total cardiac events (hard events, revascularization and hospitalization) (p < 0.001). The annual hard events rates were 0.4%, 2.3%, and 7.0% in the normal, mild, and moderate-severe groups, respectively. In adjusted survival models, 82Rb PET SSS was the strongest predictor of total cardiac events and a significant predictor of hard events. Among patients referred for PET after 99mTc single-photon emission computed tomography, the annual total event rate was higher with abnormal versus normal SSS on PET (15.2% vs. 1.3%, p < 0.001). In patients with obesity, the annual total event rate was 11.1% with an abnormal scan and 1.5% with a normal scan (p < 0.001). CONCLUSIONS: This study shows that 82Rb PET MPI has significant prognostic value for predicting cardiac events, including death and MI. It also seems to have prognostic value in patients whose diagnosis remains uncertain after single-photon emission computed tomography MPI and in obese patients. The prognostic value of PET MPI may improve the management of cardiac patients. 相似文献
133.
Nancy I Thomas Norman DePaul Brown Linda C Hodges Jay Gandy Louanne Lawson Janet E Lord David K Williams 《AAOHN journal》2006,54(1):24-31
The Central Arkansas Veterans Healthcare System (CAVHS) spends $1 million annually on occupational illnesses and injuries. To address the problem of injuries among hospital employees, a retrospective case-control study was conducted to examine select risk factors for work-related injuries (WRI) among CAVHS employees. Study methods included a review of employee health charts and computer and manual databases from 1997 to 2002 (N = 2,050). The researchers found that WRI increased with age; WRI occurred more often in women than in men; WRI was greater among maintenance and custodial staff compared to direct caregivers, and less among clerical staff; WRI occurred less often in part-time than full-time staff; and WRI increased with increasing body mass index. Developing standards, guidelines, and policies for preplacement screening, preventive measures, training, and education may help to minimize WRI and associated costs. 相似文献
134.
135.
Robert L. Kriel MD Linda E. Krach MD Martha M. Bergland MS Laurel A. Panser MS 《Pediatric neurology》1988,4(6):337-341
This report describes the outcomes of 28 children who had severe head injuries between 13–18 years of age. All were unconscious at least 24 hours and have been followed at least 2 years after injury. At present, their ages range from 18 to 27 years. Their educational achievements, social activities, marital status, functional independence, and employment at follow-up are described. 相似文献
136.
Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi 总被引:6,自引:4,他引:2
Iraj Khalkhali Ismael Mena Linda Diggles 《European journal of nuclear medicine and molecular imaging》1994,21(4):357-362
Imaging techniques currently used for the diagnosis of breast cancer are reviewed and compared. Besides mammography, magnetic resonance imaging, positron emission tomography, and thallium-201 scintimammography, a new role of technetium-99m sestamibi scintimammography is discussed. It is concluded that while mammography remains the procedure of choice in screening asymptomatic women for breast cancer, other imaging methods play an important role in detecting malignancies in symptomatic patients.99mTc-sestamibi scintimammography has high sensitivity and improves the specificity of conventional mammography for the detection of breast cancer; with this technique, prone imaging is preferable to supine imaging.99mTc-sestamibi scintimammography thus deserves further study as a screening technique. 相似文献
137.
138.
Comfort management is a priority for patients in all settings. Comfort theory provides a foundational and holistic approach to comfort management. This article reviews comfort theory and presents the application of comfort theory in the perianesthesia setting. OBJECTIVES: -Based on the content of the following article, the reader will be able to (1) define comfort; (2) identify comfort interventions; and (3) discuss the importance of a goal for enhanced comfort in patients. 相似文献
139.
Jenny E Westin Linda Vercammen Elissa M Strome Christine Konradi M Angela Cenci 《Neuropsychopharmacology》2007,62(7):800-810
BACKGROUND: We examined the activation pattern of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and its dependence on D1 versus D2 dopamine receptors in hemiparkinsonian rats treated with 3,4-dihydroxyphenyl-L-alanine (L-DOPA). METHODS: 6-Hydroxydopamine-lesioned rats were treated acutely or chronically with L-DOPA in combination with antagonists for D1 or D2 receptors. Development of dyskinesia was monitored in animals receiving chronic drug treatment. Phosphorylation of ERK1/2, mitogen- and stress-activated protein kinase-1 (MSK-1), and the levels of FosB/DeltaFosB expression were examined immunohistochemically. RESULTS: L-DOPA treatment caused phosphorylation of ERK1/2 in the dopamine-denervated striatum after acute and chronic administration. Similar levels were observed in matrix and striosomes, and in enkephalin-positive and dynorphin-positive neurons. The severity of dyskinesia was positively correlated with phospho-ERK1/2 levels. Phosphorylation of ERK1/2 and MSK-1 was dose-dependently blocked by SCH23390, but not by raclopride. SCH23390 also inhibited the development of dyskinesia and the induction of FosB/DeltaFosB. CONCLUSIONS: L-DOPA produces pronounced activation of ERK1/2 signaling in the dopamine-denervated striatum through a D1-receptor-dependent mechanism. This effect is associated with the development of dyskinesia. Phosphorylated ERK1/2 is localized to both dynorphinergic and enkephalinergic striatal neurons, suggesting a general role of ERK1/2 as a plasticity molecule during L-DOPA treatment. 相似文献
140.
L M Delahanty R W Grant E Wittenberg J L Bosch D J Wexler E Cagliero J B Meigs 《Diabetic medicine》2007,24(1):48-54
AIMS: To characterize the determinants of diabetes-related emotional distress by treatment modality (diet only, oral medication only, or insulin). METHODS: A total of 815 primary care patients with Type 2 diabetes completed the Problem Areas in Diabetes (PAID) Scale and other questions. We linked survey data to a diabetes clinical research database and used linear regression models to assess the associations of treatment with PAID score. RESULTS: PAID scores were significantly higher among insulin-treated (24.6) compared with oral-treated (17.8, P < 0.001) or diet-treated patients (14.7, P < 0.001), but not different between oral- vs. diet-treated patients (P = 0.2). Group scores remained similar, but the statistical significance of their differences was reduced and ultimately eliminated after sequential adjustment for diabetes severity, HbA(1c), body mass index, regimen adherence, and self-blood-glucose monitoring. Insulin-treated patients reported significantly higher distress than oral- or diet-treated patients on 16 of 20 PAID items. 'Worrying about the future' and 'guilt/anxiety when ... off track with diabetes' were the top two serious problems (PAID >or= 5) in all treatment groups. Not accepting diabetes diagnosis was a top concern for oral- and diet-treated patients, and unclear management goals distressed diet-treated patients. CONCLUSIONS: Primary care patients treated with insulin reported higher diabetes-related emotional distress compared with oral- or diet-treated patients. Greater distress was largely explained by greater disease severity and self-care burdens. To improve diabetes-specific quality of life, clinicians should address patients' sense of worry and guilt, uncertain acceptance of diabetes diagnosis, and unclear treatment goals. 相似文献